|
May 9
|
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
|
|
May 7
|
Clover Health Investments, Corp. (CLOV) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 2
|
Senseonics Holdings, Inc. to Participate in Upcoming Conferences
|
|
May 1
|
Senseonics gets FDA clearance to pair CGM implant with insulin pumps
|
|
Apr 30
|
Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
|
|
Apr 30
|
Eversense® CGM System Receives iCGM Designation by the US FDA
|
|
Mar 12
|
SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS
|
|
Mar 8
|
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
|
|
Mar 6
|
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
|
|
Feb 6
|
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
|